What We Have Learnt from PACE Multicenter, International Phase 3 Randomized Controlled Study
This content is only accessible to Accuray Exchange (AEx) members. Username Password Remember Me Forgot Password
From the Crystal Study with Extreme Hypofractionation to Moderate Hypofractionation
This content is only accessible to Accuray Exchange (AEx) members.
Accuray Alliance: A Partnership in Care
Chris McDaniel | Accuray Incorporated | ASTRO 2022 AEx Academy
Improving Outcomes Through the Use of Live Tumor Tracking with Synchrony®
Jimm Grimm, Ph.D., DABR | Geisinger Medical Center, Danville, Pennsylvania | ASTRO 2022 AEx Academy
Prostate SBRT and the PACE-B Trial
Alison Tree, MBBS, BSc, FRCR, M.D.(Res) | Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, UK | ASTRO 2022 AEx Academy
UTSW Experience: Ultra-Hypofractionated Breast Radiation
Asal Shoushtari Rahimi, M.D., MS | U.T. Southwestern Medical Center, Dallas, Texas | ASTRO 2022 AEx Academy
Treating Challenging Cases using the CyberKnife® Treatment Delivery System
Simeon Hodges, MSc. | Columbus CyberKnife, Westerville, OH | ASTRO 2022 AEx Academy
Clinical Value of Motion Synchronization for Prostate SBRT
Sean Collins, M.D., Ph.D. | MedStar Georgetown University Hospital, Georgetown University School of Medicine, Washington, D.C. | ASTRO 2022 AEx Academy
Integration of Brainlab Elements in a CyberKnife SRS Program
This content is only accessible to Accuray Exchange (AEx) members.
Changing Paradigms for the Treatment of Multiple Brain Metastases- Why Brainlab Elements software is beneficial for a Successful Intracranial Radiosurgery Program
This content is only accessible to Accuray Exchange (AEx) members.